FATE · ISSUER CIK 1434316
FATE THERAPEUTICS INC
Between Aug 1, 2026 and Oct 29, 2026, 2 FATE THERAPEUTICS INC insiders reported $0.00 of open-market purchases and $204K of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 2 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$204KInsider selling
−$204KNet open-market
Aug 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 202616:03 | Aug 4, 2026 | FATE | See Remarks | S · Sell | $2.46 | −38,800 | 589,355 | -6% | −$95K | ||
| Aug 5, 202616:01 | Aug 4, 2026 | FATE | President and CEO, Director | S · Sell | $2.46 | −43,947 | 591,815 | -7% | −$108K |